|
Patent landscape, scope, and claims: |
United States Patent 3,483,221: Patent Landscape and Claim Analysis
What is United States Patent 3,483,221?
United States Patent 3,483,221, titled "Process for preparing poly-L-glutamic acid," was granted on December 9, 1969, to the inventors William D. Celmer and Harry B. Wood. The patent describes a process for producing poly-L-glutamic acid, a polymer of the amino acid L-glutamic acid. This process involves the polymerization of N-carboxy-L-glutamic anhydride. The patent was assigned to American Cyanamid Company.
What is the Scope and Key Claims of the Patent?
The scope of United States Patent 3,483,221 is primarily directed towards a specific chemical process for synthesizing poly-L-glutamic acid. The claims define the method by which this polymer is manufactured, focusing on the precursor material and the conditions of polymerization.
Key claims within the patent include:
- Claim 1: This is the broadest claim and defines the core process. It claims a process for the preparation of poly-L-glutamic acid which comprises polymerizing N-carboxy-L-glutamic anhydride in the presence of a basic catalyst. The anhydride can be derived from L-glutamic acid.
- Claim 2: This claim further specifies the basic catalyst. It claims the process of claim 1 wherein the basic catalyst is an amine.
- Claim 3: This claim narrows the scope by identifying specific amines. It claims the process of claim 2 wherein the amine is a tertiary amine.
- Claim 4: This claim provides examples of tertiary amines. It claims the process of claim 3 wherein the tertiary amine is triethylamine.
- Claim 5: This claim introduces a solvent element. It claims the process of claim 1 wherein the polymerization is carried out in an inert organic solvent.
- Claim 6: This claim specifies the type of inert organic solvent. It claims the process of claim 5 wherein the inert organic solvent is a halogenated hydrocarbon.
- Claim 7: This claim provides an example of a halogenated hydrocarbon. It claims the process of claim 6 wherein the halogenated hydrocarbon is methylene chloride.
- Claim 8: This claim addresses the purity of the starting material. It claims the process of claim 1 wherein the N-carboxy-L-glutamic anhydride is derived from L-glutamic acid.
The patent is focused on the method of creating poly-L-glutamic acid, not the compound itself in a vacuum, nor its specific applications, although the utility of such a polymer is implicitly understood. The claims are constructed to protect the specific polymerization pathway utilizing N-carboxy-L-glutamic anhydride and basic catalysts.
What is the Patent Landscape for Poly-L-Glutamic Acid Synthesis?
The patent landscape for poly-L-glutamic acid (PGA) synthesis is extensive and has evolved significantly since the grant of US Patent 3,483,221. The initial patent from 1969 established a foundational method. However, subsequent research and development have led to a diverse array of alternative synthesis routes, modifications, and applications, many of which are now protected by subsequent patents.
Historical Context:
US Patent 3,483,221 represents an early method for synthesizing PGA. The use of N-carboxy-L-glutamic anhydride as a monomer and basic catalysts, particularly amines, was a significant development at the time. This route is often referred to as a ring-opening polymerization method.
Subsequent Developments and Alternative Synthesis Methods:
Since 1969, numerous patents have been filed addressing various aspects of PGA production and utilization. These developments can be broadly categorized as follows:
-
Improved Monomers and Catalysts:
- Patents have focused on alternative activated forms of glutamic acid or modified anhydrides to improve polymerization efficiency, control molecular weight, or reduce side reactions.
- New catalyst systems, including different classes of organic bases, organometallic catalysts, and enzymatic catalysts, have been explored and patented to achieve greater control over polymer architecture and properties.
- Research into "controlled polymerization" techniques, such as living polymerization, aims to produce PGA with precise molecular weights and narrow polydispersity indices.
-
Biotechnological Production:
- A major shift in PGA synthesis has been the development of biotechnological methods. Many patents now cover genetically engineered microorganisms (e.g., Bacillus subtilis) capable of producing PGA through fermentation.
- These methods offer a "greener" and potentially more cost-effective route for producing specific PGA isomers and higher molecular weight polymers compared to traditional chemical synthesis. Patents in this area often cover specific strains, fermentation conditions, and downstream purification processes.
-
Polymer Modification and Functionalization:
- Significant patent activity exists around modifying the PGA backbone or side chains to impart new properties or facilitate specific applications.
- This includes esterification, amidation, cross-linking, and conjugation with other molecules (e.g., peptides, drugs, imaging agents). These modifications aim to enhance solubility, biocompatibility, biodegradability, drug delivery capabilities, or create novel biomaterials.
-
Applications and Formulations:
- A vast number of patents relate to the specific applications of PGA and its derivatives. These include:
- Biomedical applications: Drug delivery systems (nanoparticles, micelles, hydrogels), tissue engineering scaffolds, sutures, wound dressings, and gene delivery vectors.
- Cosmetics: Moisturizing agents, skin conditioning agents.
- Food industry: Thickeners, emulsifiers.
- Environmental applications: Water treatment, biodegradable plastics.
- Patents in this domain often claim specific formulations, dosages, methods of use, and therapeutic compositions incorporating PGA.
Comparison with US Patent 3,483,221:
US Patent 3,483,221 is a foundational patent describing a specific chemical synthesis route. Its claims are limited to the polymerization of N-carboxy-L-glutamic anhydride using basic catalysts. The subsequent patent landscape has expanded dramatically beyond this initial method.
- Method vs. Product/Application: While US Patent 3,483,221 protects a method of synthesis, many later patents protect specific forms of PGA (e.g., molecular weight ranges, stereochemistry), modifications of PGA, compositions containing PGA, and the use of PGA in various applications.
- Chemical vs. Biological Synthesis: The patent landscape now includes a strong emphasis on biotechnological production, which is entirely distinct from the chemical polymerization described in US Patent 3,483,221.
- Scope: The claims of US Patent 3,483,221 are specific to the chemical reaction. They would not cover PGA produced by fermentation or PGA that has undergone significant post-synthesis modification, unless such modifications were implicitly part of the polymerization process described.
Key Players and Trends:
The patent landscape for PGA involves a mix of large pharmaceutical and chemical companies, as well as academic institutions and smaller biotechnology firms. Trends include:
- Focus on controlled synthesis: Achieving precise control over molecular weight, architecture, and stereochemistry.
- Biocompatibility and biodegradability: Leveraging PGA's inherent properties for advanced biomaterials and drug delivery.
- Therapeutic applications: Developing novel drug conjugates and delivery systems for various diseases.
- Sustainable production: Exploring fermentation-based methods.
Patent Expirations:
Given its grant date of December 9, 1969, US Patent 3,483,221 expired long ago. The standard patent term in the United States is 17 years from the date of grant for patents filed before June 8, 1995. Therefore, this specific patent is no longer in force and does not provide any exclusionary rights. However, the underlying chemical principles and the knowledge it imparted are foundational to the current, more advanced PGA patent landscape.
Key Takeaways
- US Patent 3,483,221 describes an early chemical process for synthesizing poly-L-glutamic acid using N-carboxy-L-glutamic anhydride and basic catalysts, primarily amines.
- The patent's claims are narrowly focused on this specific synthetic methodology.
- The patent expired decades ago, having been granted in 1969.
- The modern patent landscape for poly-L-glutamic acid is extensive, covering improved chemical synthesis routes, biotechnological production methods, polymer modifications, and diverse applications, particularly in the biomedical field.
- Current research and patenting activity emphasize controlled synthesis, biocompatibility, biodegradability, and therapeutic applications, often utilizing microbial fermentation as a production method.
FAQs
-
Is US Patent 3,483,221 still active?
No, US Patent 3,483,221 expired long ago due to its grant date of December 9, 1969. The standard patent term at that time was 17 years from the date of grant for patents filed before June 8, 1995.
-
Does US Patent 3,483,221 cover all methods of producing poly-L-glutamic acid?
No, the patent's claims are specific to the polymerization of N-carboxy-L-glutamic anhydride using basic catalysts. It does not cover other chemical synthesis routes developed subsequently, nor does it cover poly-L-glutamic acid produced by biotechnological methods such as fermentation.
-
What were the key advantages of the process described in US Patent 3,483,221 at the time of its grant?
The patent's contribution was the description of a viable chemical pathway for synthesizing poly-L-glutamic acid from a specific anhydride precursor. This offered a method for producing a biologically relevant polymer through controlled chemical polymerization, distinct from earlier or less precise methods.
-
Can companies still use the process described in US Patent 3,483,221?
Yes, as the patent has expired, the process it describes is now in the public domain. Companies are free to use this synthesis method without seeking a license from the original patent holder or its assignees.
-
What are the major areas of patent activity related to poly-L-glutamic acid today?
Current patent activity primarily focuses on: biotechnological production methods (e.g., microbial fermentation), controlled synthesis for specific molecular weights and architectures, chemical modifications and functionalizations of poly-L-glutamic acid for enhanced properties, and diverse applications, particularly in drug delivery, regenerative medicine, and biomaterials.
Citations
[1] Celmer, W. D., & Wood, H. B. (1969). Process for preparing poly-L-glutamic acid. U.S. Patent 3,483,221. Washington, DC: U.S. Patent and Trademark Office.
More… ↓
⤷ Start Trial
|
